Oscar Health shares are trading higher after Goldman Sachs maintained a Neutral rating on the stock and raised its price target from $8 to $16.
Portfolio Pulse from Benzinga Newsdesk
Oscar Health's stock price increased following Goldman Sachs' decision to maintain a Neutral rating on the stock while raising its price target from $8 to $16.
February 09, 2024 | 7:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oscar Health's stock price is likely to experience a short-term increase following Goldman Sachs' updated price target from $8 to $16, despite maintaining a Neutral rating.
The increase in Oscar Health's price target by a reputable financial institution like Goldman Sachs can lead to positive investor sentiment, potentially driving up the stock price in the short term. The decision to maintain a Neutral rating suggests caution, but the significant raise in the price target is likely to be the dominant factor influencing investor behavior.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90